Nothing Special   »   [go: up one dir, main page]
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2008 3
2009 1
2010 2
2011 6
2012 6
2013 9
2014 9
2015 10
2016 13
2017 14
2018 25
2019 28
2020 24
2021 25
2022 29
2023 31
2024 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
An Update on the Genetics of IgA Nephropathy.
Xu LL, Zhou XJ, Zhang H. Xu LL, et al. J Clin Med. 2023 Dec 25;13(1):123. doi: 10.3390/jcm13010123. J Clin Med. 2023. PMID: 38202130 Free PMC article. Review.
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Shadman M, et al. Among authors: xu l. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16. Lancet Haematol. 2023. PMID: 36400069 Clinical Trial.
3CLpro inhibitors: DEL-based molecular generation.
Xiong F, Xu H, Yu M, Chen X, Zhong Z, Guo Y, Chen M, Ou H, Wu J, Xie A, Xiong J, Xu L, Zhang L, Zhong Q, Huang L, Li Z, Zhang T, Jin F, He X. Xiong F, et al. Among authors: xu l. Front Pharmacol. 2022 Dec 7;13:1085665. doi: 10.3389/fphar.2022.1085665. eCollection 2022. Front Pharmacol. 2022. PMID: 36569316 Free PMC article.
Uromodulin and progression of IgA nephropathy.
Chen Z, Xu LL, Du W, Ouyang Y, Gu X, Fang Z, Yu X, Li J, Xie L, Jin Y, Ma J, Wang Z, Pan X, Zhang W, Ren H, Wang W, Chen X, Zhou XJ, Zhang H, Chen N, Xie J. Chen Z, et al. Clin Kidney J. 2024 Jul 15;17(8):sfae209. doi: 10.1093/ckj/sfae209. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39145144 Free PMC article.
242 results